Serum levels of substance P and response to antidepressant pharmacotherapy.
Substance P (SP) is possibly involved in the etiopathology of affective disorders. Here we investigated the relationship of SP serum levels and response to antidepressant drug therapy. SP serum levels were determined before and during a 9-week drug trial in 40 depressed patients treated with paroxetine in combination with either lamotrigine (n = 20) or placebo (n = 20). Responders (n = 18) and non-responders (n = 22) significantly differed in SP serum levels: responders started with higher SP levels that decreased during drug therapy, whereas non-responders had lower SP levels that increased at the beginning. There were no differences between patients with adjunct lamotrigine or placebo. These preliminary data indicate that SP serum levels might be related to response to antidepressant drug therapy. Further studies have to substantiate this finding.
K
K
Lieb
J
J
Walden
H
H
Grunze
B L
BL
Fiebich
M
M
Berger
C
C
Normann
D000208:Acute Disease; D000328:Adult; D000928:Antidepressive Agents / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000077213:Lamotrigine; D017374:Paroxetine / Q000009:adverse effects*; D012720:Severity of Illness Index; D013373:Substance P / Q000097:blood / Q000378:metabolism*; D011795:Surveys and Questionnaires; D014227:Triazines / Q000009:adverse effects*
D000928:Antidepressive Agents; D014227:Triazines; D013373:Substance P; D017374:Paroxetine; D000077213:Lamotrigine